1.
Rigorous Bivariate Synthesis of Benefit-Risk Profiles for Direct Oral Anticoagulants in Atrial Fibrillation. ST. 2026;1(1). Accessed June 16, 2026. https://synthesis-medicine.org/index.php/journal/article/view/12